Is polypharmacy a major cause of geriatric syndromes?

Polypharmacy rarely causes geriatric syndromes alone—it's part of a dangerous cluster

The strongest evidence shows that polypharmacy is a major contributor to geriatric syndromes, but it almost never operates in isolation. In a 2026 multicenter cohort study of 2,556 hospitalized older adults (average age 79), polypharmacy was present in 61.7% of patients, making it the second most common geriatric syndrome after disability [1]. Critically, patients had a median of 5 geriatric syndromes simultaneously, and each additional syndrome increased the risk of death within 90 days by 22% [1]. This means polypharmacy is dangerous not just by itself, but because it tends to cluster with frailty, disability, falls, and cognitive impairment—together creating a much higher risk than any single condition.

A 2023 review on older adults with cardiovascular disease reinforces this point: it identifies polypharmacy as one of several non-cardiovascular factors—alongside multimorbidity, frailty, and geriatric syndromes—that together drive functional decline and worsen prognosis [5]. The takeaway: if you have polypharmacy, you likely have other geriatric syndromes too, and that combination is what really matters.

Polypharmacy is strongly linked to cognitive decline—but not in every frail population

The link between polypharmacy and cognitive impairment is well-established, but a surprising finding from one study shows this relationship isn't universal. A 2021 review reports that older adults with mild cognitive impairment who took more than 3 drugs per day had six times higher odds of progressing to dementia within a year, with drug-drug interactions accounting for 70% of that association [4]. Anticholinergic drugs were especially harmful, causing worse memory and psychomotor speed [4].

However, a 2024 study of 1,391 homebound or bedbound frail elders in low-resource Brazilian communities found the opposite: polypharmacy was negatively associated with cognitive impairment (odds ratio 0.61, meaning it was less common in those with cognitive decline) [2]. This counterintuitive result likely reflects the specific population—these were extremely frail, homebound individuals where dementia was the primary cause of cognitive impairment (82% of cases), and polypharmacy may have been less common because of limited healthcare access or because clinicians avoid multiple medications in very frail patients [2]. So while polypharmacy clearly drives cognitive decline in many older adults, its role can be overshadowed by other factors in the most vulnerable groups.

Chronic kidney disease dramatically amplifies the risk from polypharmacy

The danger of polypharmacy is not the same for everyone—it's much worse in older adults with kidney disease. A 2022 study of 1,320 older patients (average age 79.6) found that those with severely reduced kidney function (GFR below 30) were twice as likely to have polypharmacy compared to those with normal kidney function [3]. In this group, the rate of having 3 or more geriatric syndromes in the same person was already 66.4% even in those with normal kidneys, and it climbed even higher as kidney function declined [3]. This matters because medications accumulate in the body when kidneys are weak, making polypharmacy more dangerous—more drug interactions, more side effects, and faster progression to frailty, falls, and cognitive decline.

The practical implication: if you have chronic kidney disease and take multiple medications, you are in a high-risk group where polypharmacy is especially likely to trigger or worsen geriatric syndromes. Geriatricians and nephrologists need to coordinate care for these patients [3].

About These Sources

This answer is built on 5 peer-reviewed studies — published from 2021 to 2026, 2 from 2024 or later, 3 in Q1 journals, collectively cited 152 times — selected as the most relevant from 6 studies that passed quality screening, drawn from 71 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions